Related Experiment Video
Updated: Aug 8, 2026

Orthotopic Implantation and Peripheral Immune Cell Monitoring in the II-45 Syngeneic Rat Mesothelioma Model
Published on: October 2, 2015
[Immunologic parameters in patients with malignant melanoma]
Insights
This study investigated melanoma patients' immune responses using lymphocyte tests. Findings suggest these tests can evaluate immune reactivity and predict prognosis in melanoma.
Area of Science:
- Immunology
- Oncology
- Cell Biology
Context:
- Malignant melanoma is a significant health concern.
- Understanding the immune system's role in melanoma is crucial for treatment and prognosis.
- Existing methods for assessing immune reactivity in cancer patients have limitations.
Purpose:
- To define the immunological reactivity of patients with malignant melanoma.
- To evaluate lymphocyte electrophoretic mobility and reactivity using poly-L-lysine agglutination and nucleolar tests.
- To correlate these immunological markers with disease progression and prognosis.
Summary:
- Lymphocyte tests, including poly-L-lysine agglutination and nucleolar tests, were performed on melanoma patients before and after tumor removal.
- Increased positive results in poly-L-lysine tests and altered lymphocyte electrophoretic mobility correlated with disease progression.
- Elevated nucleolar coefficients and active nucleoli indicated higher immune reactivity, while declining ring-shaped nucleoli suggested immunologic exhaustion.
Impact:
- The study provides valuable insights into the immunological status of melanoma patients.
- The findings suggest that these lymphocyte-based assays can be used to assess immune reactivity and predict outcomes in melanoma.
- This research may contribute to the development of more personalized treatment strategies for melanoma.
Abstract:
In an attempt to better define the immunological reactivity of patients with malignant melanoma, the electrophoretic mobility of lymphocytes and their reactivity were studied in poly-L-lysine agglutination and in nucleolar test. Blood samples were examined before treatment and repeatedly after surgical removal of the tumor. A microagglutination test induced by poly-L-lysine was used for the detection of sensitized lymphocytes in peripheral blood of melanoma patients. The number of positive results was increasing with the progression of the disease. After incubation with poly-L-lysine the electrophoretic mobility of lymphocytes was changed in melanoma patients. The nucleolar test was used for the study of quantitative and morphological changes of the nucleoli in lymphocytes. Elevated values of the nucleolar coefficient and an increased number of active nucleoli provided evidence on the higher immunological reactivity of melanoma patients. The decline in the number of lymphocytes with ring-shaped nucleoli, signaling immunologic exhaustion, are of prognostic value. Lymphocytes were assayed also for the presence of receptors for sheep erythrocytes (E active and total rosettes) and C3d component of complement (EAC rosettes). The reported findings may be used to advantage in evaluating the immunological reactivity of melanoma patients.
Related Concept Videos
Skin Cancer
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Tumor Immunotherapy

